Role of neoadjuvant chemotherapy in the management of advanced ovarian yolk sac tumor

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Ignace Vergote, Claes G. Tropé, Frédéric Amant et al. · New England Journal of Medicine · 2010 · 2.5K citations · Full text

Medicine, Oncology, Surgery +17

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.

Stephen Williams, J A Blessing, S Y Liao et al. · Journal of Clinical Oncology · 1994 · 345 citations

Medicine, Oncology, Surgery +17

The United Kingdom Children’s Cancer Study Group’s Second Germ Cell Tumor Study: Carboplatin, Etoposide, and Bleomycin Are Effective Treatment for Children With Malignant Extracranial Germ Cell Tumors, With Acceptable Toxicity

Jillian R. Mann, F. Raafat, Katie Robinson et al. · Journal of Clinical Oncology · 2000 · 277 citations

Medicine, Oncology, Pediatrics +17

Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma

Walther Kuhn, Stefan Rutke, K Späthe et al. · Cancer · 2001 · 211 citations

Medicine, Oncology, Surgery +17

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease☆

Jinlin Hou, Martina Kelly, Hon J. Yu et al. · Gynecologic Oncology · 2007 · 176 citations

Medicine, Oncology, Surgery +17